Justin Kenkel
About Justin Kenkel
Justin Kenkel is a Principal Scientist currently at Bolt Biotherapeutics, Inc., where he has worked since 2021. He has extensive experience in immunology and pathology, having held various research positions at institutions such as Stanford University and the University of Washington.
Current Role at Bolt Biotherapeutics
Justin Kenkel serves as Principal Scientist at Bolt Biotherapeutics, Inc. since 2021. In this role, he focuses on advancing the company's research initiatives in biotherapeutics. His leadership contributes to the development of innovative treatments aimed at improving patient outcomes.
Previous Experience at Bolt Biotherapeutics
Justin Kenkel previously held two positions at Bolt Biotherapeutics, Inc. He worked as Scientist II from 2018 to 2019, where he contributed to various research projects. Following this, he served as Senior Scientist from 2019 to 2021, further enhancing his expertise in the field of biotherapeutics.
Educational Background
Justin Kenkel earned his Bachelor's Degree in Molecular and Cell Biology from the University of California, Berkeley, where he studied from 2002 to 2006. He later pursued a Doctor of Philosophy (Ph.D.) in Immunology at Stanford University, completing his studies from 2007 to 2014.
Research Experience at Stanford University
At Stanford University School of Medicine, Justin Kenkel held two significant roles. He was a Graduate Student Researcher in Immunology from 2007 to 2014, followed by a position as Postdoctoral Fellow in Pathology from 2015 to 2018. These roles provided him with extensive research experience in immunology and pathology.
Early Career and Internships
Justin Kenkel began his career with a role as a Pharmacopathology Intern at Berlex Biosciences from 2005 to 2006. He also worked as a Research Scientist in Rheumatology at the University of Washington from 2006 to 2007, gaining valuable experience in research methodologies and scientific inquiry.